Article Versions Notes

Halwe S, Kupke A, Vanshylla K, Liberta F, Gruell H, Zehner M, Rohde C, Krähling V, Gellhorn Serra M, Kreer C, et al. Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses. 2021; 13(8):1498. https://doi.org/10.3390/v13081498

Halwe, Sandro, Alexandra Kupke, Kanika Vanshylla, Falk Liberta, Henning Gruell, Matthias Zehner, Cornelius Rohde, Verena Krähling, Michelle Gellhorn Serra, Christoph Kreer, and et al. 2021. "Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection" Viruses 13, no. 8: 1498. https://doi.org/10.3390/v13081498

Halwe, S., Kupke, A., Vanshylla, K., Liberta, F., Gruell, H., Zehner, M., Rohde, C., Krähling, V., Gellhorn Serra, M., Kreer, C., Klüver, M., Sauerhering, L., Schmidt, J., Cai, Z., Han, F., Young, D., Yang, G., Widera, M., Koch, M., ... Becker, S. (2021). Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Viruses, 13(8), 1498. https://doi.org/10.3390/v13081498